NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Forxiga HF General Drug Use-Results Study

NCT04865406

CompletedN/A

Sponsor: AstraZeneca

Conditions: Heart Failure

Countries: Japan

To capture safety when Forxiga is administered to patients with HF in clinical practice after launch.

Eligibility overview

Sex: ALL

Age: 15 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Patients aged more than 15 years
* Patients who have been prescribed Forxiga for the first time

Exclusion Criteria:

* Patients with a history of hypersensitivity to any ingredients of this drug.
* Patients with severe ketosis, diabetic coma or precoma
* Patients with severe infections, before or after a surgery, or with serious trauma

Locations (45)

Aichi, Japan
Akita, Japan
Aomori, Japan
Chiba, Japan
Ehime, Japan
Fukui, Japan
Fukuoka, Japan
Fukushima, Japan
Gifu, Japan
Gunma, Japan
Hiroshima, Japan
Hokkaido, Japan
Hyōgo, Japan
Ibaraki, Japan
Ishikawa, Japan
Kagawa, Japan
Kagoshima, Japan
Kanagawa, Japan
Kochi, Japan
Kumamoto, Japan
Kyoto, Japan
Mie, Japan
Miyagi, Japan
Miyazaki, Japan
Nagano, Japan
Nagasaki, Japan
Nara, Japan
Numakunai, Japan
Okayama, Japan
Okinawa, Japan
+ 15 more on CT.gov